About this trial
The study, named as "The Efficacy of Driving Pressure-guided Lung Protective Ventilation in Surgical Repair of Acute Type A Aortic Dissection: an open-label, randomized control clinical trial", aims to investigate whether driving pressure-guided lung protective ventilation can reduce postoperative oxygenation function in patients who have undergone surgical repair of acute type A aortic dissection. The primary outcomes is the incidence of postoperative hypoxemia (a partial pressure of arterial oxygen to inspiratory oxygen fraction ratio less than 300 mm Hg or a peripheral blood oxygen saturation less than 93% at any concentration of inspiratory oxygen) within 7 days after the surgery.
Eligibility criteria
Qualifiers
Able to sign Informed Consent and Release of Medical Information Forms;
Age ≥ 14 years and ≤ 70 years old;
Being confirmed the diagnosis by chest computed tomography angiography and receiving the surgical repair of acute type A aortic dissection.
Disqualifiers
Age < 14 years or > 70 years old;
Sepsis before surgery;
Chronic pulmonary disease including lung infection or asthma requiring long-term pharmacotherapy;
History of lung tumor;
Trial design
Treatments tested in this trial
- Driving pressure-guided positive end expiratory pressure
- Optimal oxygenation-guided positive end expiratory pressure
- Ventilation strategy
- Management of hypoxemia
Treatment groups
Sponsors and collaborators
Yong Lin, PhD
Lead sponsor
Fujian Medical University Union Hospital
Sponsor institution